This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Berkshire Shares Sell for Bargain Prices

NEW YORK ( TheStreet) -- Glenn Tongue, co-manager of the Tilson Focus Fund (TILFX), says Berkshire Hathaway's (BRK.B - Get Report) stock remains cheap despite recent gains. Shares of Warren Buffett's investment company could keep climbing, he says.

The $16 million fund, which garners three stars from Morningstar (MORN), has doubled during the past year, better than 98% of rival funds. The fund has climbed 5.7% annually, on average, during the past five years, outperforming 88% of competitors.

Welcome to TheStreet's Fund Manager Five Spot, where America's top mutual fund managers give their best stock picks in five fast and furious questions.

Are you finding value in the market right now?

Tongue: Absolutely. A year ago it was real easy. A year ago the challenge was to stay invested. You have to be much more selective now but there are great opportunities if you are willing to do the work to dig into these companies.

Is Berkshire Hathaway still a buy? It's had a nice little spike since the split.

Tongue: It's had a nice run. It's still our largest position and we think it is cheap. It's safe, it's fast growing and it's cheap. The operating businesses are worth about $40 per share. And the cash and marketable securities like Coca-Cola (KO) and American Express (AXP) on the balance sheet, we think are worth about $60 a share. So that's maybe $100 a share that the company is worth and it's trading at around $80 a share.

What's your view on General Growth Properties (GGP)? What do you think the end game is?

Tongue: Well, General Growth was a dollar a share a year ago and it's now $15 a share. But for an acquirer like Simon Properties (SPG) it's worth well over $20 a share. So I expect they are going to come back with an attractive bid and there are also other suitors in the wings.

Boston Scientific (BSX) has been having some big problems recently. You are getting into the stock. Why?

Tongue: It's all a question of price. Any company out there is worth a certain value, and Boston Scientific got down to our threshold. We thought at $7 to $8 a share it was interesting opportunity. And when it dropped by over a dollar a few days ago it became a high priority opportunity for us.

Another stock you like is Iridium Communications (IRDM). The original Iridium was in bankruptcy a while ago. It has since come back. Why do you like this stock?

Tongue: You're right. It was in bankruptcy, but it was a different company back then. It was a consumer-based company. This stock is about the cheapest company we have in our portfolio and one of the cheapest we have seen in many years. It's trading at about 3 times operating cash flow. It is growing at 20% a year. It generates about $150 million in cash every year. We think this company is extraordinarily cheap, very well run and has a huge runway for many years.

-- Reported by Gregg Greenberg in New York.

Before joining TheStreet.com, Gregg Greenberg was a writer and segment producer for CNBC's Closing Bell. He previously worked at FleetBoston and Lehman Brothers in their Private Client Services divisions, covering high net-worth individuals and midsize hedge funds. Greenberg attended New York University's School of Business and Economic Reporting. He also has an M.B.A. from Cornell University's Johnson School of Business, and a B.A. in history from Amherst College.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
BRK.A $217,000.10 0.00%
BRK.B $143.89 0.00%
AAPL $123.25 0.00%
FB $83.30 0.00%
GOOG $548.34 0.00%

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs